2019
Special contribution, on the occasion of the Foundation San Salvatore’s fortieth Anniversaries to the project
Disabling Disease Progression Under Androgen Deprivation: The Clue to Prostate Cancer Cure Steroid-hormone driven cancers, prostate cancer, disease progression, androgen deprivation, epigenetic re-programming, immune evasion, EZH2, TNF, alpha.
Researchers to the Institute of Oncology Research, IOR, Bellinzona, (Switzerland)
- Prof.Dr.med Jean-Philippe Theurillat
Group Leader Funcional Cancer Genomics - Prof.Dr.med Carlo Catapano Director,
Group Leader and Head of the Cancer Biology and Experimental Therapeutics - Prof.MD Andrea Alimonti
Group Leader of Molecular Oncology - MD Giuseppina Carbone
Director of the Prostate Cancer Biology Laboratory
2009
Special contribution, on the occasion of the Foundation San Salvatore’s thirtieth anniversary for the support of volunteer service for oncology patients.
- Lega ticinese contro il cancro
- Associazione Triangolo
- Hospice Ticino
- Croce Rossa Ticino
- Rete Due Uno (Pro Infirmis)
- Fondazione Elisa
- Associazione ILCO Ticino
- Laringectomizzati of Southern Switzerland
2004
Special contribution, on the occasion of the Foundation San Salvatore's twenty-fifth anniversary in favor of doctoral candidates for the support for research in bio-medicine.
- IRB Istituto di Ricerca in Biomedicina, Bellinzona (Switzerland).
Special contribution, on the occasion of the Foundation San Salvatore's twenty-fifth anniversary in favor of doctoral candidates for the support of research in oncology.
- IOSI Istituto Oncologico della Svizzera Italiana, Bellinzona (Switzerland).
1999
Special contribution, on the occasion of the Foundation San Salvatore's twentieth anniversary in favor of doctoral candidates for the support of research in bio-medicine.
- IRB Istituto di Ricerca in Biomedicina, Bellinzona (Switzerland).
1989
Special contribution for the tenth anniversary of the Foundation San Salvatore, for in depth examination of the "action of weak ionizing radiation on human cells and the possible transformation of these into cancerous cells."
- KISK Commission of the Swiss Cancer League, Bern (Switzerland).